company background image
AHCO

AdaptHealthNasdaqCM:AHCO Stock Report

Market Cap

US$2.7b

7D

-9.4%

1Y

-32.6%

Updated

30 Nov, 2021

Data

Company Financials +
AHCO fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health1/6
Dividends0/6

AHCO Stock Overview

AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States.

AdaptHealth Competitors

Amazon.com

NasdaqGS:AMZN

US$1.8t

CVS Health

NYSE:CVS

US$121.6b

Apria

NasdaqGS:APR

US$1.0b

Inogen

NasdaqGS:INGN

US$709.0m

Price History & Performance

Summary of all time highs, changes and price drops for AdaptHealth
Historical stock prices
Current Share PriceUS$20.14
52 Week HighUS$41.58
52 Week LowUS$20.11
Beta-0.053
1 Month Change-26.09%
3 Month Change-16.22%
1 Year Change-32.55%
3 Year Changen/a
5 Year Changen/a
Change since IPO109.79%

Recent News & Updates

Nov 11
AdaptHealth (NASDAQ:AHCO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

AdaptHealth (NASDAQ:AHCO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

AdaptHealth Corp. ( NASDAQ:AHCO ) announced strong profits, but the stock was stagnant. Our analysis suggests that...

Nov 03
Is AdaptHealth (NASDAQ:AHCO) Using Too Much Debt?

Is AdaptHealth (NASDAQ:AHCO) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Sep 23
Is AdaptHealth Corp. (NASDAQ:AHCO) Trading At A 48% Discount?

Is AdaptHealth Corp. (NASDAQ:AHCO) Trading At A 48% Discount?

In this article we are going to estimate the intrinsic value of AdaptHealth Corp. ( NASDAQ:AHCO ) by projecting its...

Shareholder Returns

AHCOUS HealthcareUS Market
7D-9.4%-0.4%-0.9%
1Y-32.6%20.7%23.3%

Return vs Industry: AHCO underperformed the US Healthcare industry which returned 20.7% over the past year.

Return vs Market: AHCO underperformed the US Market which returned 23.3% over the past year.

Price Volatility

Is AHCO's price volatile compared to industry and market?
AHCO volatility
AHCO Average Weekly Movement5.2%
Healthcare Industry Average Movement6.3%
Market Average Movement6.0%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.3%

Stable Share Price: AHCO is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: AHCO's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a4,700Luke McGeehttps://www.adapthealth.com

AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors.

AdaptHealth Fundamentals Summary

How do AdaptHealth's earnings and revenue compare to its market cap?
AHCO fundamental statistics
Market CapUS$2.66b
Earnings (TTM)US$40.15m
Revenue (TTM)US$2.10b

66.3x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AHCO income statement (TTM)
RevenueUS$2.10b
Cost of RevenueUS$1.64b
Gross ProfitUS$463.97m
ExpensesUS$423.83m
EarningsUS$40.15m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.30
Gross Margin22.08%
Net Profit Margin1.91%
Debt/Equity Ratio111.2%

How did AHCO perform over the long term?

See historical performance and comparison

Valuation

Is AdaptHealth undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: AHCO ($20.14) is trading below our estimate of fair value ($49.1)

Significantly Below Fair Value: AHCO is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: AHCO is poor value based on its PE Ratio (66.3x) compared to the US Healthcare industry average (21x).

PE vs Market: AHCO is poor value based on its PE Ratio (66.3x) compared to the US market (17.1x).


Price to Earnings Growth Ratio

PEG Ratio: AHCO is poor value based on its PEG Ratio (2.4x)


Price to Book Ratio

PB vs Industry: AHCO is good value based on its PB Ratio (1.3x) compared to the US Healthcare industry average (2.8x).


Future Growth

How is AdaptHealth forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?

27.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AHCO's forecast earnings growth (27.7% per year) is above the savings rate (2%).

Earnings vs Market: AHCO's earnings (27.7% per year) are forecast to grow faster than the US market (14.3% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: AHCO's revenue (13.5% per year) is forecast to grow faster than the US market (10.1% per year).

High Growth Revenue: AHCO's revenue (13.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: AHCO's Return on Equity is forecast to be low in 3 years time (11.3%).


Past Performance

How has AdaptHealth performed over the past 5 years?

-45.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AHCO has a large one-off loss of $90.5M impacting its September 30 2021 financial results.

Growing Profit Margin: AHCO became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: AHCO has become profitable over the past 5 years, growing earnings by -45.6% per year.

Accelerating Growth: AHCO has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: AHCO has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (32.5%).


Return on Equity

High ROE: AHCO's Return on Equity (2.2%) is considered low.


Financial Health

How is AdaptHealth's financial position?


Financial Position Analysis

Short Term Liabilities: AHCO's short term assets ($823.4M) exceed its short term liabilities ($502.1M).

Long Term Liabilities: AHCO's short term assets ($823.4M) do not cover its long term liabilities ($2.7B).


Debt to Equity History and Analysis

Debt Level: AHCO's net debt to equity ratio (94.3%) is considered high.

Reducing Debt: Insufficient data to determine if AHCO's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: AHCO's debt is not well covered by operating cash flow (10.1%).

Interest Coverage: AHCO's interest payments on its debt are not well covered by EBIT (2.8x coverage).


Balance Sheet


Dividend

What is AdaptHealth current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AHCO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AHCO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AHCO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AHCO's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AHCO's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.2yrs

Average management tenure


CEO

Luke McGee (37 yo)

0.67

Tenure

US$1,009,533

Compensation

Mr. Luke McGee serves as the Chief Executive Officer of QMES Holdings LLC since November 11, 2017. Mr. McGee has been Co-Chief Executive Officer at AdaptHealth Corp. since February 2, 2021 and served on th...


CEO Compensation Analysis

Compensation vs Market: Luke's total compensation ($USD1.01M) is below average for companies of similar size in the US market ($USD5.21M).

Compensation vs Earnings: Luke's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: AHCO's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

Experienced Board: AHCO's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: AHCO insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 47.5%.


Top Shareholders

Company Information

AdaptHealth Corp.'s employee growth, exchange listings and data sources


Key Information

  • Name: AdaptHealth Corp.
  • Ticker: AHCO
  • Exchange: NasdaqCM
  • Founded: NaN
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Implied Market Cap: US$2.663b
  • Market Cap: US$2.663b
  • Shares outstanding: 132.22m
  • Website: https://www.adapthealth.com

Number of Employees


Location

  • AdaptHealth Corp.
  • 220 West Germantown Pike
  • Suite 250
  • Plymouth Meeting
  • Pennsylvania
  • 19462
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/30 00:32
End of Day Share Price2021/11/29 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.